Pharmacoepidemiology in the era of real-world evidence.
作者信息
Toh Sengwee
机构信息
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
出版信息
Curr Epidemiol Rep. 2017 Dec;4(4):262-265. doi: 10.1007/s40471-017-0123-y. Epub 2017 Oct 19.
Abstract
摘要
相似文献
1
Pharmacoepidemiology in the era of real-world evidence.真实世界证据时代的药物流行病学
Curr Epidemiol Rep. 2017 Dec;4(4):262-265. doi: 10.1007/s40471-017-0123-y. Epub 2017 Oct 19.
2
Identification and mapping of worldwide sources of generic real-world data.全球通用真实世界数据来源的识别与映射。
Pharmacoepidemiol Drug Saf. 2019 Jul;28(7):899-905. doi: 10.1002/pds.4782. Epub 2019 May 6.
3
Pharmacoepidemiology of statins.他汀类药物的药物流行病学
Therapie. 2019 Apr;74(2):261-269. doi: 10.1016/j.therap.2019.01.004. Epub 2019 Jan 18.
4
Real-World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG).真实世界证据：根据国际药物流行病学学会（ISPE）比较有效性研究（CER）特别兴趣小组（SIG）的定义及其能告诉我们的内容。
Clin Pharmacol Ther. 2018 Aug;104(2):239-241. doi: 10.1002/cpt.1086. Epub 2018 May 7.
5
A history of pharmacoepidemiology.药物流行病学史。
Therapie. 2019 Apr;74(2):175-179. doi: 10.1016/j.therap.2018.10.003. Epub 2018 Oct 19.
6
Pharmacoepidemiology Research-Real-World Evidence for Decision Making.药物流行病学研究——用于决策的真实世界证据
Front Pharmacol. 2021 Sep 7;12:723427. doi: 10.3389/fphar.2021.723427. eCollection 2021.
7
Profiling real-world data sources for pharmacoepidemiologic research: A call for papers.为药物流行病学研究剖析真实世界数据源：征文启事。
Pharmacoepidemiol Drug Saf. 2022 Sep;31(9):929-931. doi: 10.1002/pds.5481. Epub 2022 Jul 3.
8
Challenges in Post-marketing Studies of Biological Drugs in the Era of Biosimilars: A Report of the International Society for Pharmacoepidemiology 2019 Mid-Year Meeting in Rome, Italy.生物类似药时代下生物药上市后研究面临的挑战：2019 年国际药物流行病学学会在意大利罗马举行的年中会议报告。
BioDrugs. 2019 Aug;33(4):345-352. doi: 10.1007/s40259-019-00365-2.
9
Pharmacoepidemiology.药物流行病学
Handb Exp Pharmacol. 2019;260:433-451. doi: 10.1007/164_2019_318.
10
Pharmacoepidemiology and Big Data Analytics: Challenges and Opportunities when Moving towards Precision Medicine.药物流行病学与大数据分析：迈向精准医学过程中的挑战与机遇
Chimia (Aarau). 2019 Dec 18;73(12):1012-1017. doi: 10.2533/chimia.2019.1012.
引用本文的文献
1
Generating fit-for-purpose real-world evidence in Asia: How far are we from closing the gaps?在亚洲生成适用的真实世界证据：我们距离弥合差距还有多远？
Perspect Clin Res. 2023 Jul-Sep;14(3):108-113. doi: 10.4103/picr.picr_193_22. Epub 2023 Jun 5.
2
Recording type 2 diabetes mellitus in a standardised central Saudi database: a retrospective validation study.在沙特中央标准化数据库中记录 2 型糖尿病：一项回顾性验证研究。
BMJ Open. 2023 Mar 21;13(3):e065468. doi: 10.1136/bmjopen-2022-065468.
3
What Can We Learn About Drug Safety and Other Effects in the Era of Electronic Health Records and Big Data That We Would Not Be Able to Learn From Classic Epidemiology?在电子健康记录和大数据时代，我们能从经典流行病学中学到哪些关于药物安全性和其他影响的知识，而这些知识是我们无法从经典流行病学中学到的？
J Surg Res. 2020 Feb;246:599-604. doi: 10.1016/j.jss.2019.09.053. Epub 2019 Oct 22.
本文引用的文献
1
Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0.报告以提高医疗保健数据库研究的可重复性并促进有效性评估V1.0版
Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1018-1032. doi: 10.1002/pds.4295.
2
Multidimensional Evidence Generation and FDA Regulatory Decision Making: Defining and Using "Real-World" Data.多维证据生成与美国食品药品监督管理局的监管决策：定义和使用“真实世界”数据
JAMA. 2017 Aug 22;318(8):703-704. doi: 10.1001/jama.2017.9991.
3
Sentinel Modular Program for Propensity Score-Matched Cohort Analyses: Application to Glyburide, Glipizide, and Serious Hypoglycemia.Sentinel 模块化倾向评分匹配队列分析计划：在格列本脲、格列吡嗪和严重低血糖中的应用。
Epidemiology. 2017 Nov;28(6):838-846. doi: 10.1097/EDE.0000000000000709.
4
Cloudy with a Chance of Pain: Engagement and Subsequent Attrition of Daily Data Entry in a Smartphone Pilot Study Tracking Weather, Disease Severity, and Physical Activity in Patients With Rheumatoid Arthritis.《多云有疼痛风险：类风湿关节炎患者智能手机试点研究中日常数据录入的参与度及后续流失情况，该研究追踪天气、疾病严重程度和身体活动》
JMIR Mhealth Uhealth. 2017 Mar 24;5(3):e37. doi: 10.2196/mhealth.6496.
5
Real-World Evidence - What Is It and What Can It Tell Us?真实世界证据——它是什么以及能告诉我们什么？
N Engl J Med. 2016 Dec 8;375(23):2293-2297. doi: 10.1056/NEJMsb1609216.
6
Successful Comparison of US Food and Drug Administration Sentinel Analysis Tools to Traditional Approaches in Quantifying a Known Drug-Adverse Event Association.美国食品药品监督管理局哨兵分析工具与传统方法在量化已知药物不良事件关联方面的成功比较。
Clin Pharmacol Ther. 2016 Nov;100(5):558-564. doi: 10.1002/cpt.429. Epub 2016 Aug 22.
7
Incorporating Patient-Reported Outcomes Into Health Care To Engage Patients And Enhance Care.将患者报告的结果纳入医疗保健，以促使患者参与并改善护理。
Health Aff (Millwood). 2016 Apr;35(4):575-82. doi: 10.1377/hlthaff.2015.1362.
8
Computer-assisted expert case definition in electronic health records.电子健康记录中的计算机辅助专家病例定义
Int J Med Inform. 2016 Feb;86:62-70. doi: 10.1016/j.ijmedinf.2015.10.005. Epub 2015 Oct 31.
9
The FDA's sentinel initiative--A comprehensive approach to medical product surveillance.美国食品药品监督管理局的哨兵计划——一种全面的医疗产品监测方法。
Clin Pharmacol Ther. 2016 Mar;99(3):265-8. doi: 10.1002/cpt.320. Epub 2016 Jan 12.
10
Guidelines for good pharmacoepidemiology practice (GPP).药物流行病学良好实践指南（GPP）。
Pharmacoepidemiol Drug Saf. 2016 Jan;25(1):2-10. doi: 10.1002/pds.3891. Epub 2015 Nov 5.
Zotero 插件